Clinical trial

Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer

NCT00231465

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-07-01

PhasePHASE2

Study timeline

Study start (unknown)2003-07-01Date precision: month

Registry last updated2017-03-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small Cell Lung Cancerunresolved

Interventions

docetaxel (Taxotere®)DRUG

ZD1839DRUG

Sponsors & collaborators

H. Lee Moffitt Cancer Center and Research Institutelead sponsor

AstraZenecacollaborator

Mapped research locations

TampaFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00231465 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.